Login / Signup

Inherited IL-18BP deficiency in human fulminant viral hepatitis.

Serkan BelkayaEleftherios MichailidisCecilia B KorolMohammad KabbaniAurélie CobatPaul BastardYoon Seung LeeNicholas HernandezScott B DrutmanYpe P de JongÉric VivierJulie BruneauVivien BéziatBertrand BoissonLazaro Lorenzo-DiazSoraya BoucheritMylène SebaghEmmanuel JacqueminJean François EmileLaurent AbelCharles M RiceEmmanuelle JouanguyJean Laurent Casanova
Published in: The Journal of experimental medicine (2019)
Fulminant viral hepatitis (FVH) is a devastating and unexplained condition that strikes otherwise healthy individuals during primary infection with common liver-tropic viruses. We report a child who died of FVH upon infection with hepatitis A virus (HAV) at age 11 yr and who was homozygous for a private 40-nucleotide deletion in IL18BP, which encodes the IL-18 binding protein (IL-18BP). This mutation is loss-of-function, unlike the variants found in a homozygous state in public databases. We show that human IL-18 and IL-18BP are both secreted mostly by hepatocytes and macrophages in the liver. Moreover, in the absence of IL-18BP, excessive NK cell activation by IL-18 results in uncontrolled killing of human hepatocytes in vitro. Inherited human IL-18BP deficiency thus underlies fulminant HAV hepatitis by unleashing IL-18. These findings provide proof-of-principle that FVH can be caused by single-gene inborn errors that selectively disrupt liver-specific immunity. They also show that human IL-18 is toxic to the liver and that IL-18BP is its antidote.
Keyphrases
  • endothelial cells
  • healthcare
  • sars cov
  • induced pluripotent stem cells
  • emergency department
  • gene expression
  • pluripotent stem cells
  • patient safety
  • deep learning
  • smoking cessation
  • nk cells